Clinical Trials Sponsored by National Institute of Mental Health, Dhaka

Total 15615 results

National Institute of Mental Health, Dhaka
Sun Pharmaceutical Industries Limited

Completed

Efficacy of Mirtazapine in Major Depressive Disorder With Insomnia

Major Depressive Disorder With Insomnia

Bangladesh
Central Institute of Mental Health, Mannheim

Not yet recruiting

Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption (NeuStress)

Craving | Alcohol Abuse | Psychosocial Stressor | Neural Stress Response

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder (A03)

Risk Behavior | Alcohol Use Disorder | Craving | Relapse | Stress Reaction | Social Stress | Addiction, Alcohol

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Selective Attention in Alcohol Use Disorder

Alcohol Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Electroconvulsive Therapy for Treatment of Alzheimer´s Disease (ECTAD)

Alzheimer's Disease
Central Institute of Mental Health, Mannheim

Completed

Evaluation of the Addictive Potential of E-Cigarettes (EVAPE)

Tobacco Use Disorder | Nicotine Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Amitriptyline and Paroxetine Treatment of Major Depression

Unipolar Depression

Germany
Central Institute of Mental Health, Mannheim

Completed

Modification of Goal-directed and Habitual Behavior in Addiction

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Investigation of Brain Oxygenation and Blood Flow in Smokers (OEF)

Cerebral Oxygenation and Blood Flow in Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Neural and Pharmacological Correlates of Intrusions in Patients With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

Healthy | Modeling Psychosis

Germany
Central Institute of Mental Health, Mannheim

Completed

Effects of THC and CBD on Human Episodic Memory Function

Healthy Volunteers

Germany
Central Institute of Mental Health, Mannheim

Completed

Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

Psychotic Disorders

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Substance Consumption, Personality, and Cognitive Functioning of Chess Players

Depression | Anxiety | Addiction | Nicotine | Personality | Alcohol | Drugs

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Modification of Cue Reactivity by Neurofeedback in Human Addiction

Alcohol Use Disorder (AUD)

Germany
Central Institute of Mental Health, Mannheim

Completed

Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents

Aggression | Conduct Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Training of Neural Responding in BPD (IP5n)

Borderline Personality Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) (AB_THC_CBD)

Healthy Humans

Germany
Central Institute of Mental Health, Mannheim

Unknown

Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe PTSD Following Sexual Abuse (PASA)

Posttraumatic Stress Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
Central Institute of Mental Health, Mannheim

Terminated

Naltrexone in Borderline Personality Disorder

Borderline Personality Disorder

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Schizophrenia

Germany
Central Institute of Mental Health, Mannheim

Recruiting

Enhancing Recovery in Early Schizophrenia

Schizophrenia

Germany
Central Institute of Mental Health, Mannheim

Not yet recruiting

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

Healthy Volunteers | Modeling Psychosis

Germany
Central Institute of Mental Health, Mannheim

Active, not recruiting

Validation of a Training Program for Patients With Alcohol Use Disorder

Alcohol Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Completed

Neurobiological Mechanisms of Chess as an Add-On Treatment Against SUD (Chess_SUD)

Substance Use Disorders

Germany
Central Institute of Mental Health, Mannheim

Completed

Targeted Extinction of Drug Cues During Sleep - Olfactory Cue Reactivity Task (TEDDS_OCRT)

Heavy Drinking

Germany
Central Institute of Mental Health, Mannheim

Completed

Reversing Maladaptive Reorganization in Frail Brains (FRAILBRAIN)

Neuroplasticity | Sensorimotor

Germany
Central Institute of Mental Health, Mannheim

Completed

Transcranial Direct Current Stimulation - Tobacco Use Disorder

Tobacco Use Disorder

Germany
Central Institute of Mental Health, Mannheim

Terminated

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Pharmacokinetics, Bioavailability

Germany
Central Institute of Mental Health, Mannheim

Completed

Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain

Chronic Lower Back Pain | Healthy Control Subjects

Germany
University of Central Florida
National Institute of Mental Health (NIMH)

Completed

Treatment of Childhood Social Phobia

Social Phobia

United States
National Institute of Neurosciences and Hospital...

Completed

Insulin for Hyperglycemia in Stroke Trial

Hyperglycemia | Stroke, Acute

Bangladesh
Central Institute of Mental Health, Mannheim
Servier

Completed

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) (AGOPSYCH)

Schizophrenia | Schizoaffective Disorder | Delusional Disorder

Germany
Central Institute of Mental Health, Mannheim
Sanofi

Completed

Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

Diabetes | Schizophrenia | Insulin Resistance

Germany
National Institute of Mental Health (NIMH)

Completed

CATIE- Schizophrenia Trial

Schizophrenia

United States
National Institute of Mental Health (NIMH)

Completed

Treatment for Adolescents With Depression Study (TADS)

Depression | Major Depressive Disorder

United States
National Institute of Mental Health (NIMH)

Completed

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) (METS)

Schizophrenia

United States
National Institute of Mental Health (NIMH)

Completed

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Depression

United States
National Institute of Mental Health (NIMH)

Completed

Ethnic Variations in Antidepressant Response

Depression

United States
National Institute of Mental Health (NIMH)

Completed

Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents

Post-Traumatic Stress Disorder

Israel
National Institute of Mental Health (NIMH)

Unknown

Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With Depression

Depression

Puerto Rico
National Institute of Mental Health (NIMH)

Completed

Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Treatment for Anxiety in Children

Obsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Social Phobia | Separation Anxiety
UConn Health
National Institute of Mental Health (NIMH); National Institutes of Health (NIH)

Recruiting

Managing Anxiety in Pediatric Primary Care (MAPP) (MAPP)

Anxiety Disorders | Anxiety

United States
National Institute of Mental Health (NIMH)
National Institute of Mental Health, Eli Lilly & Co.

Completed

Imaging of Cannabinoid Receptors Using New Radioactive Tracer

Healthy

United States
National Institute of Mental Health (NIMH)

Completed

Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine

Major Depressive Disorder

United States
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder (LiTMUS)

Bipolar Disorder

United States
National Institute of Mental Health (NIMH)

Withdrawn

Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum Period

Bipolar Disorder

United States

Clinical Trials Sponsored by National Institute of Mental Health, Dhaka

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations